<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK55063" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK55063/" /><meta name="ncbi_pagename" content="Branchiooculofacial Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Branchiooculofacial Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Branchiooculofacial Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/03/29" /><meta name="citation_author" content="Angela E Lin" /><meta name="citation_author" content="Chad R Haldeman-Englert" /><meta name="citation_author" content="Jeff M Milunsky" /><meta name="citation_pmid" content="21634087" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK55063/" /><meta name="citation_keywords" content="BOF Syndrome" /><meta name="citation_keywords" content="BOF Syndrome" /><meta name="citation_keywords" content="Transcription factor AP-2-alpha" /><meta name="citation_keywords" content="TFAP2A" /><meta name="citation_keywords" content="Branchiooculofacial Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Branchiooculofacial Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Angela E Lin" /><meta name="DC.Contributor" content="Chad R Haldeman-Englert" /><meta name="DC.Contributor" content="Jeff M Milunsky" /><meta name="DC.Date" content="2018/03/29" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK55063/" /><meta name="description" content="The branchiooculofacial syndrome (BOFS) is characterized by: branchial (cervical or infra- or supra-auricular) skin defects that range from barely perceptible thin skin or hair patch to erythematous &quot;hemangiomatous&quot; lesions to large weeping erosions; ocular anomalies that can include microphthalmia, anophthalmia, coloboma, and nasolacrimal duct stenosis/atresia; and facial anomalies that can include ocular hypertelorism or telecanthus, broad nasal tip, upslanted palpebral fissures, cleft lip or prominent philtral pillars that give the appearance of a repaired cleft lip (formerly called &quot;pseudocleft lip&quot;) with or without cleft palate, upper lip pits, and lower facial weakness (asymmetric crying face or partial 7th cranial nerve weakness). Malformed and prominent pinnae and hearing loss from inner ear and/or petrous bone anomalies are common. Intellect is usually normal." /><meta name="og:title" content="Branchiooculofacial Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="The branchiooculofacial syndrome (BOFS) is characterized by: branchial (cervical or infra- or supra-auricular) skin defects that range from barely perceptible thin skin or hair patch to erythematous &quot;hemangiomatous&quot; lesions to large weeping erosions; ocular anomalies that can include microphthalmia, anophthalmia, coloboma, and nasolacrimal duct stenosis/atresia; and facial anomalies that can include ocular hypertelorism or telecanthus, broad nasal tip, upslanted palpebral fissures, cleft lip or prominent philtral pillars that give the appearance of a repaired cleft lip (formerly called &quot;pseudocleft lip&quot;) with or without cleft palate, upper lip pits, and lower facial weakness (asymmetric crying face or partial 7th cranial nerve weakness). Malformed and prominent pinnae and hearing loss from inner ear and/or petrous bone anomalies are common. Intellect is usually normal." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK55063/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/bofs/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK55063/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A41A0E04093810000000003260135.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK55063_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK55063_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/bohring-opitz/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bor/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK55063_"><span class="title" itemprop="name">Branchiooculofacial Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: BOF Syndrome</div><p class="contrib-group"><span itemprop="author">Angela E Lin</span>, MD, FAAP, FACMG, <span itemprop="author">Chad R Haldeman-Englert</span>, MD, and <span itemprop="author">Jeff M Milunsky</span>, MD, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK55063_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK55063_ai__"><div class="contrib half_rhythm"><span itemprop="author">Angela E Lin</span>, MD, FAAP, FACMG<div class="affiliation small">Genetics Unit<br />Massachusetts General Hospital for Children<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.hgm@alegna.nil" class="oemail">ude.dravrah.hgm@alegna.nil</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Chad R Haldeman-Englert</span>, MD<div class="affiliation small">Fullerton Genetics Center<br />Asheville, North Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.jsm@trelgne-namedlah.dahc" class="oemail">gro.jsm@trelgne-namedlah.dahc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Jeff M Milunsky</span>, MD, FACMG<div class="affiliation small">Director, Clinical Genetics<br />Senior Director, Molecular Genetics<br />Co-Director<br />Center for Human Genetics, Inc<br />Cambridge, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cnighc@yksnulimj" class="oemail">gro.cnighc@yksnulimj</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 31, 2011</span>; Last Update: <span itemprop="dateModified">March 29, 2018</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="bofs.Summary" itemprop="description"><h2 id="_bofs_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The branchiooculofacial syndrome (BOFS) is characterized by: branchial (cervical or infra- or supra-auricular) skin defects that range from barely perceptible thin skin or hair patch to erythematous "hemangiomatous" lesions to large weeping erosions; ocular anomalies that can include microphthalmia, anophthalmia, coloboma, and nasolacrimal duct stenosis/atresia; and facial anomalies that can include ocular hypertelorism or telecanthus, broad nasal tip, upslanted palpebral fissures, cleft lip or prominent philtral pillars that give the appearance of a repaired cleft lip (formerly called "pseudocleft lip") with or without cleft palate, upper lip pits, and lower facial weakness (asymmetric crying face or partial 7th cranial nerve weakness). Malformed and prominent pinnae and hearing loss from inner ear and/or petrous bone anomalies are common. Intellect is usually normal.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis is based on clinical findings and confirmed with the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TFAP2A</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> In general, children with BOFS should be managed by a multispecialty team including, for example, craniofacial specialists, plastic surgeons, otolaryngologists, and speech therapists. Small, linear or superficial branchial skin defects may heal spontaneously; however, some require surgical intervention. Anophthalmia or severe microphthalmia may require a conformer (a structure, usually plastic, inserted into the eye socket to encourage its growth); nasolacrimal duct stenosis or atresia often requires surgery. It is recommended that cleft lip be repaired by an experienced pediatric plastic surgeon. Lesser forms of cleft lip ("pseudocleft") may need surgical correction.</p><p><i>Surveillance:</i> Monitor for changes related to the major findings over time as directed by the team of specialists.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>BOFS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. <i>De novo</i> pathogenic variants are observed in 50%-60% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Each child of an individual with BOFS has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Once the <i>TFAP2A</i> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="bofs.Diagnosis"><h2 id="_bofs_Diagnosis_">Diagnosis</h2><p>The branchiooculofacial syndrome (BOFS) is diagnosed clinically. There are no formal diagnostic guidelines developed by consensus panels, algorithms using a hierarchy of clinical findings, or evidence-based test standards.</p><p>Diagnostic criteria had been used informally based on the hallmark defects (B, O, F) and were proposed formally in 2011 incorporating the importance of thymic anomalies and independently diagnosed first-degree relatives [<a class="bk_pop" href="#bofs.REF.milunsky.2011.22">Milunsky et al 2011</a>] (Table I).</p><p>Note: Of the original three features that comprise the mnemonic BOF, the "B" (cutaneous skin defect) is the most distinctive when it is bilateral and anterior cervical in location.</p><div id="bofs.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Branchiooculofacial syndrome (BOFS) <b>should be suspected</b> in individuals with findings in two or three of the following categories:</p><p><b>Branchial (cutaneous) defects.</b> Cervical or infra- or supra-auricular <b>skin defects</b>:</p><ul><li class="half_rhythm"><div>Vary from barely perceptible thin skin or hair patch to erythematous "hemangiomatous" lesions to large weeping erosions;</div></li><li class="half_rhythm"><div>Differ from the punctuate sinus tracts of the <a href="/books/n/gene/bor/">branchiootorenal (BOR) syndrome</a></div></li><li class="half_rhythm"><div>If very mild, may be unrecognized and heal spontaneously, but tend to "weep"</div></li></ul><p><b>Ocular anomalies</b></p><ul><li class="half_rhythm"><div>Microphthalmia, anophthalmia</div></li><li class="half_rhythm"><div>Coloboma</div></li><li class="half_rhythm"><div>Cataract</div></li><li class="half_rhythm"><div>Ptosis</div></li><li class="half_rhythm"><div>Nasolacrimal duct stenosis/atresia</div></li><li class="half_rhythm"><div>Strabismus</div></li></ul><p><b>Facial anomalies</b></p><ul><li class="half_rhythm"><div>Characteristic appearance with dolichocephaly, hypertelorism or telecanthus, broad nasal tip, upslanted palpebral fissures (<a class="figpopup" href="/books/NBK55063/figure/bofs.F1/?report=objectonly" target="object" rid-figpopup="figbofsF1" rid-ob="figobbofsF1">Figure 1</a>)</div></li><li class="half_rhythm"><div>Cleft lip or prominent philtral pillars (technically known as a lesser-form cleft lip [formerly "pseudocleft lip"]), with or without cleft palate, but no <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> cleft palate</div></li><li class="half_rhythm"><div>Upper lip pits</div></li><li class="half_rhythm"><div>Lower facial nerve and/or muscle hypoplasia (asymmetric crying face, partial 7th cranial nerve weakness)</div></li><li class="half_rhythm"><div>Inner ear and petrous bone anomalies such as cochlear dysplasia, Mondini dysplasia, and enlarged vestibular aqueduct</div></li><li class="half_rhythm"><div>Malformed and prominent pinnae</div></li><li class="half_rhythm"><div>Hearing loss (conductive, sensorineural, mixed)</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figbofsF1" co-legend-rid="figlgndbofsF1"><a href="/books/NBK55063/figure/bofs.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figbofsF1" rid-ob="figobbofsF1"><img class="small-thumb" src="/books/NBK55063/bin/bofs-Image001.gif" src-large="/books/NBK55063/bin/bofs-Image001.jpg" alt="Figure 1. . Photo of a boy age five years with the BOF syndrome." /></a><div class="icnblk_cntnt" id="figlgndbofsF1"><h4 id="bofs.F1"><a href="/books/NBK55063/figure/bofs.F1/?report=objectonly" target="object" rid-ob="figobbofsF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Photo of a boy age five years with the BOF syndrome. Details of the molecular findings are reported in Milunsky et al [2008] (patient 3, age 2 years). He has a right-sided cervical cutaneous defect ("B") that was repaired; bilateral nasolacrimal duct <a href="/books/NBK55063/figure/bofs.F1/?report=objectonly" target="object" rid-ob="figobbofsF1">(more...)</a></p></div></div></div><div id="bofs.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of BOFS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who meets the following clinical diagnostic criteria and confirmed by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TFAP2A</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK55063/table/bofs.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figbofsTmoleculargenetictestingusedin" rid-ob="figobbofsTmoleculargenetictestingusedin">Table 1</a>). Diagnostic criteria:</p><ul><li class="half_rhythm"><div>All three of the main features are present:</div><ul><li class="half_rhythm"><div>Branchial (cutaneous) skin defect</div></li><li class="half_rhythm"><div>Ocular anomaly</div></li><li class="half_rhythm"><div>Facial anomalies (characteristic facial appearance)</div></li></ul><div>OR</div></li><li class="half_rhythm"><div>Two of the three main features plus one of the following are present:</div><ul><li class="half_rhythm"><div>Affected <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a>, independently diagnosed</div></li><li class="half_rhythm"><div>Ectopic thymus (dermal)</div></li></ul></li></ul><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of BOFS is broad, individuals with the distinctive features described in <a href="#bofs.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#bofs.Option_1">Option 1</a>), whereas those in whom the diagnosis of BOFS has not been considered are more likely to be diagnosed using genomic testing (see <a href="#bofs.Option_2">Option 2</a>).</p><div id="bofs.Option_1"><h4>Option 1</h4><p>When the phenotypic findings suggest the diagnosis of BOFS <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>TFAP2A</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>TFAP2A</i> and other genes of interest (see <a href="#bofs.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For this disorder a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that also includes <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is recommended (see <a class="figpopup" href="/books/NBK55063/table/bofs.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figbofsTmoleculargenetictestingusedin" rid-ob="figobbofsTmoleculargenetictestingusedin">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="bofs.Option_2"><h4>Option 2</h4><p>When the diagnosis of BOFS is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is the most commonly used genomic testing method; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><p><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is non-diagnostic.</p><div id="bofs.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Branchiooculofacial Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK55063/table/bofs.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bofs.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bofs.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_bofs.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_bofs.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_bofs.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>TFAP2A</i></td><td headers="hd_h_bofs.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_bofs.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;95%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_bofs.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_bofs.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="bofs.TF.1.1"><p class="no_margin">See <a href="/books/NBK55063/#bofs.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="bofs.TF.1.2"><p class="no_margin">See <a href="#bofs.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="bofs.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="bofs.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#bofs.REF.milunsky.2011.22">Milunsky et al [2011]</a></p></div></dd><dt>5. </dt><dd><div id="bofs.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="bofs.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#bofs.REF.milunsky.2008.1171">Milunsky et al [2008]</a>, <a class="bk_pop" href="#bofs.REF.gestri.2009.791">Gestri et al [2009]</a></p></div></dd></dl></div></div></div></div></div></div><div id="bofs.Clinical_Characteristics"><h2 id="_bofs_Clinical_Characteristics_">Clinical Characteristics</h2><div id="bofs.Clinical_Description"><h3>Clinical Description</h3><p>Most individuals with branchiooculofacial syndrome (BOFS) can be diagnosed in infancy on the basis of their clinical features. Females and males are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> equally.</p><div id="bofs.Classic_BOF_Findings"><h4>Classic BOF Findings</h4><p><b>Branchial (cutaneous) defects</b> occur in a cervical (90%) or infra- or supra-auricular (60%) location.</p><ul><li class="half_rhythm"><div>Defects vary from barely perceptible thin skin or hair patch to erythematous "hemangiomatous" lesions to large weeping erosions.</div></li><li class="half_rhythm"><div>Mildest defects may be unrecognized and in rare cases heal completely spontaneously. There may be a small residual sinus or tract which may appear to "weep," revealing the patency.</div></li></ul><p><b>Ocular anomalies</b> include the following:</p><ul><li class="half_rhythm"><div>Structural eye malformations such as</div><ul><li class="half_rhythm"><div>Microphthalmia, anophthalmia</div></li><li class="half_rhythm"><div>Coloboma</div></li><li class="half_rhythm"><div>Cataract</div></li></ul></li><li class="half_rhythm"><div>Periorbital abnormalities such as</div><ul><li class="half_rhythm"><div>Ptosis</div></li><li class="half_rhythm"><div>Nasolacrimal duct stenosis/atresia leading to weeping eyes</div></li></ul></li><li class="half_rhythm"><div>Visual concerns such as</div><ul><li class="half_rhythm"><div>Strabismus</div></li><li class="half_rhythm"><div>Significant visual impairment</div></li></ul></li></ul><p><b>Facial anomalies.</b> Characteristic appearance includes dolichocephaly, hypertelorism or telecanthus, broad nasal tip, and upslanted palpebral fissures (see <a class="figpopup" href="/books/NBK55063/figure/bofs.F1/?report=objectonly" target="object" rid-figpopup="figbofsF1" rid-ob="figobbofsF1">Figure 1</a>). Other findings may include:</p><ul><li class="half_rhythm"><div>Cleft lip or prominent philtral pillars (technically known as a lesser-form cleft lip [formerly "pseudocleft lip"])</div><ul><li class="half_rhythm"><div>Occurring with or without cleft palate (99%)</div></li><li class="half_rhythm"><div>No instances of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> cleft palate reported</div></li></ul></li><li class="half_rhythm"><div>Upper lip pits</div></li><li class="half_rhythm"><div>Lower facial nerve and/or muscle hypoplasia (asymmetric crying face, partial 7th cranial nerve weakness)</div></li><li class="half_rhythm"><div>Ear anomalies</div><ul><li class="half_rhythm"><div>Malformed and prominent pinnae</div></li><li class="half_rhythm"><div>Inner ear and petrous bone anomalies such as cochlear dysplasia, Mondini dysplasia, and enlarged vestibular aqueduct</div></li><li class="half_rhythm"><div>Hearing loss (70%) (conductive, sensorineural, mixed)</div></li></ul></li><li class="half_rhythm"><div>Broad nose with full nasal tip, which is distinct from the appearance of the nose in other individuals with cleft lip</div></li></ul></div><div id="bofs.Additional_Findings_Observed_in_BOF"><h4>Additional Findings Observed in BOFS</h4><p><b>Immune system.</b> Thymic anomalies (ectopic, dermal) (~35%), typically bilateral with normal thymic function</p><p><b>Renal system</b></p><ul><li class="half_rhythm"><div>Structural anomalies (35%) (e.g., dysplastic, absent, multicystic)</div></li><li class="half_rhythm"><div>Vesicoureteral reflux</div></li></ul><p><b>Ectodermal (hair, teeth, nails)</b></p><ul><li class="half_rhythm"><div>Premature hair graying, poliosis (forelock or patchy) (35%)</div></li><li class="half_rhythm"><div>Hypoplastic teeth</div></li><li class="half_rhythm"><div>Dysplastic nails</div></li><li class="half_rhythm"><div>Cysts, subcutaneous (dermoid-like, often on the scalp; less commonly in the head and neck region)</div></li></ul><p><b>Psychomotor development</b> (typically normal)</p><ul><li class="half_rhythm"><div>Visual and hearing handicaps (frequent)</div></li><li class="half_rhythm"><div>Autism spectrum disorder, intellectual disability (rare)</div></li></ul><p><b>Growth restriction.</b> Uncommon</p><p><b>Miscellaneous</b>
<b>and rare</b> (&#x0003c;5 individuals each)</p><ul><li class="half_rhythm"><div>Heterochromia irides</div></li><li class="half_rhythm"><div>Congenital heart defect (atrial septal defect, tetralogy of Fallot)</div></li><li class="half_rhythm"><div>Polydactyly (bilateral, usually postaxial)</div></li><li class="half_rhythm"><div>Medulloblastoma (described once [<a class="bk_pop" href="#bofs.REF.milunsky.2008.1171">Milunsky et al 2008</a>])</div></li></ul></div></div><div id="bofs.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No clear <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation exists.</p><p>Significant inter- and <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> were observed with the same pathogenic variants [<a class="bk_pop" href="#bofs.REF.milunsky.2011.22">Milunsky et al 2011</a>]. Missense, frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants along with more complex rearrangements [<a class="bk_pop" href="#bofs.REF.tekin.2009.427">Tekin et al 2009</a>, <a class="bk_pop" href="#bofs.REF.milunsky.2011.22">Milunsky et al 2011</a>] throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> result in similar phenotypes.</p><p>The majority of individuals with a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> involving <i>TFAP2A</i> appear to have an abnormally prominent philtrum that may be on the spectrum of microform cleft lip [<a class="bk_pop" href="#bofs.REF.lin.2009.608">Lin et al 2009</a>]. <a class="bk_pop" href="#bofs.REF.leblanc.2013.901">LeBlanc et al [2013]</a> described an infant and mother with a 593-kb deletion including <i>TFAP2A</i> and five additional genes. Neither is reported to have any type of cleft or abnormal philtrum. Otherwise the marked inter- and <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> appear similar to that observed with intragenic pathogenic variants.</p></div><div id="bofs.Penetrance"><h3>Penetrance</h3><p>BOFS has shown almost complete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. Careful examination of individuals identified in a family with BOFS with a <i>TFAP2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is necessary to reveal subtle findings including premature graying (individuals may have dyed their hair), faint hair on the neck, or heterochromia of the irides.</p></div><div id="bofs.Prevalence"><h3>Prevalence</h3><p>The prevalence of BOFS is not known. It is a rare condition, with fewer than 150 individuals having a well-described clinical and/or molecular diagnosis. An informal survey of clinical geneticists who attended a 2017 dysmorphology conference identified an additional 27 unpublished individuals (18 with a clinical diagnosis and 9 with a molecular diagnosis). While these numbers are insufficient to calculate a population-based prevalence, they support the impression that BOFS remains a rare disorder.</p></div></div><div id="bofs.Genetically_Related_Allelic_Disorde"><h2 id="_bofs_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>TFAP2A.</i></p></div><div id="bofs.Differential_Diagnosis"><h2 id="_bofs_Differential_Diagnosis_">Differential Diagnosis</h2><div id="bofs.T.disorders_to_consider_in_the_diff" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of BOFS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK55063/table/bofs.T.disorders_to_consider_in_the_diff/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bofs.T.disorders_to_consider_in_the_diff_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features</th></tr><tr><th headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4" id="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping</th><th headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4" id="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing</th></tr></thead><tbody><tr><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bor/">Branchiootorenal (BOR) spectrum disorders</a></td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EYA1</i><br /><i>SIX5</i><br /><i>SIX1</i></td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ear abnormalities</div></li><li class="half_rhythm"><div>Branchial abnormalities</div></li><li class="half_rhythm"><div>Renal abnormalities</div></li></ul>
</td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In BOR spectrum disorders:
<ul><li class="half_rhythm"><div>No BOFS facial features</div></li><li class="half_rhythm"><div>Branchial pits (vs draining sinuses w/overlying skin defects in BOFS)</div></li></ul>
</td></tr><tr><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/charge/">CHARGE syndrome</a></td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CHD7</i></td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Eye abnormalities</div></li><li class="half_rhythm"><div>Ear abnormalities</div></li><li class="half_rhythm"><div>Orofacial cleft</div></li></ul>
</td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In CHARGE syndrome:
<ul><li class="half_rhythm"><div>No skin defects</div></li><li class="half_rhythm"><div>No premature grey hair</div></li><li class="half_rhythm"><div>No BOFS facial features</div></li><li class="half_rhythm"><div>Frequent posterior segment coloboma &#x00026; choanal atresia</div></li></ul>
</td></tr><tr><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/gr_22q11deletion/">22q11.2 deletion syndrome (DS)</a></td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a></td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Eye abnormalities</div></li><li class="half_rhythm"><div>Ear abnormalities</div></li><li class="half_rhythm"><div>Branchial abnormalities</div></li><li class="half_rhythm"><div>Renal abnormalities</div></li><li class="half_rhythm"><div>Orofacial cleft</div></li></ul>
</td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In 22q11.2DS:
<ul><li class="half_rhythm"><div>No BOFS facial features</div></li><li class="half_rhythm"><div>Cardiac defects common</div></li></ul>
</td></tr><tr><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Waardenburg syndrome (WS)<br />(see <a href="/books/n/gene/ws1/">WS1</a>)</td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PAX3</i><br /><i>MITF</i><br /><i>EDNRB</i><br /><i>EDN3</i><br /><i>SNAI1</i><br /><i>SNAI2</i><br /><i>SOX10</i></td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR</td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Premature greying of hair</div></li><li class="half_rhythm"><div>Telecanthus</div></li><li class="half_rhythm"><div>Hearing loss</div></li></ul>
</td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In WS:
<ul><li class="half_rhythm"><div>No renal abnormalities</div></li><li class="half_rhythm"><div>No BOFS facial features</div></li></ul>
</td></tr><tr><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EEC3<br />(see <a href="/books/n/gene/aec/"><i>TP63</i>-Related Disorders</a>)</td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TP63</i></td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Orofacial cleft</div></li><li class="half_rhythm"><div>Ectodermal abnormalities</div></li></ul>
</td><td headers="hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_bofs.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In EEC3:
<ul><li class="half_rhythm"><div>Ectrodactyly</div></li><li class="half_rhythm"><div>No BOFS facial features</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a></p></div></dd><dt></dt><dd><div><p class="no_margin">BOFS = branchiooculofacial syndrome</p></div></dd><dt></dt><dd><div><p class="no_margin">BOR = branchiootorenal syndrome</p></div></dd><dt></dt><dd><div><p class="no_margin">EEC3 = ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3</p></div></dd></dl></div></div></div></div><div id="bofs.Management"><h2 id="_bofs_Management_">Management</h2><div id="bofs.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with the branchiooculofacial syndrome (BOFS), the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Examination of the skin defects by a pediatric plastic surgeon to delineate the extent of the lesion(s), to determine if there is a sinus and, most importantly, to determine if a thymic remnant could be present</div></li><li class="half_rhythm"><div>Complete eye examination by a pediatric ophthalmologist to assess for visual limitations, strabismus, and nasolacrimal duct obstruction</div></li><li class="half_rhythm"><div>Referral of those with anophthalmia and/or severe microphthalmia to support services for the visually impaired</div></li><li class="half_rhythm"><div>Formal evaluation of cleft lip/palate and other possible facial abnormalities by a cleft lip/palate team, which often includes a clinical geneticist, pediatric plastic surgeon, otorhinolaryngologist, audiologist, speech and language therapist, and dental and orthodontic specialist</div></li><li class="half_rhythm"><div>Hearing evaluation</div></li><li class="half_rhythm"><div>CT imaging of the temporal bone to anticipate optimal hearing correction [<a class="bk_pop" href="#bofs.REF.raveh.2000.149">Raveh et al 2000</a>, <a class="bk_pop" href="#bofs.REF.stoetzel.2009.2141">Stoetzel et al 2009</a>, <a class="bk_pop" href="#bofs.REF.tekin.2009.427">Tekin et al 2009</a>]</div></li><li class="half_rhythm"><div>Renal ultrasonography with referral to a nephrologist if renal abnormalities are identified</div></li><li class="half_rhythm"><div>Development assessment particularly for children with visual and/or hearing problems</div></li><li class="half_rhythm"><div>Monitoring for depression, attention dysregulation, autism, intellectual disability</div></li><li class="half_rhythm"><div>Echocardiogram if there is a murmur or cardiac symptoms</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul><p>Note: (1) Motor delays are not part of BOFS; thus, physical and occupational therapy is not anticipated. (2) The role of cancer surveillance is not established.</p></div><div id="bofs.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><a class="bk_pop" href="#bofs.REF.milunsky.2011.22">Milunsky et al [2011]</a> provided management guidelines which remain clinically useful and have not been updated.</p><p>In general, children with BOFS and multiple anomalies should be followed in a setting in which multispecialty care can be provided by a team including, for example, craniofacial specialists, plastic surgeons, otolaryngologists, and speech therapists (adapted from <a class="bk_pop" href="#bofs.REF.milunsky.2011.22">Milunsky et al [2011]</a>, Table IV).</p><p>Ideally, multispecialty evaluations and surgery should be performed within a craniofacial clinic.</p><ul><li class="half_rhythm"><div>Surgical treatment should be done only by a pediatric plastic surgeon experienced in treating cleft lip. Lesser forms of cleft lip (formerly known as "pseudocleft") may need surgical correction [<a class="bk_pop" href="#bofs.REF.lin.2009.608">Lin et al 2009</a>].</div></li><li class="half_rhythm"><div>In addition to the nasal tip flattening or asymmetry that may be associated with cleft lip, a characteristic full, flat nasal tip may need a corrective procedure.</div></li><li class="half_rhythm"><div>Affected individuals may need reconstruction of malformed protruding pinnae. If diagnosed in early infancy, auricular molding may be indicated.</div></li><li class="half_rhythm"><div>When branchial or supra-auricular skin defects are small, linear, or superficial, they may heal spontaneously.</div></li><li class="half_rhythm"><div>The larger skin defects may resemble a moist "wound" and often need surgical intervention. They should not be cauterized. Most larger skin defects require surgical excision.</div></li><li class="half_rhythm"><div>Importantly, a sinus tract must be dissected by an experienced pediatric plastic surgeon.</div><ul><li class="half_rhythm"><div>Exploration for a thymic remnant may be necessary; such tissue should be sent for histopathologic examination.</div></li><li class="half_rhythm"><div>If dermal thymic tissue is present, evaluate for mediastinal thymic tissue prior to excision of the ectopic thymus.</div></li></ul></li></ul><p>Ophthalmic concerns are best addressed by a pediatric ophthalmologist.</p><ul><li class="half_rhythm"><div>Obstruction from nasolacrimal duct stenosis or atresia must be relieved and individuals monitored for restenosis.</div></li><li class="half_rhythm"><div>Severe microphthalmia or anophthalmia may be managed by inserting a conformer into the eye socket to encourage its growth.</div></li></ul><p>Hearing loss is treated routinely (see <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>).</p><p>Renal and cardiac abnormalities are managed in a standard manner.</p><p>The teeth should be monitored for size and number, caries, and malocclusion.</p><p>Sensory, psychologic, and developmental challenges should be treated with supportive therapies. Currently, data are insufficient to recommend requiring more psychologic support for more severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="bofs.Surveillance"><h3>Surveillance</h3><p>Monitor for changes over time related to the major findings as directed by the team of specialists.</p><p>Monitor older children as they enter adolescence for signs of low self-esteem and other psychologic issues.</p></div><div id="bofs.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known</div></li><li class="half_rhythm"><div>A careful physical examination to look for subtle physical findings of BOFS if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known</div></li></ul><p>See <a href="#bofs.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="bofs.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="bofs.Genetic_Counseling"><h2 id="_bofs_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="bofs.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Branchiooculofacial syndrome (BOFS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="bofs.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>~40%-50% of individuals diagnosed with BOFS have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent [<a class="bk_pop" href="#bofs.REF.milunsky.2011.22">Milunsky et al 2011</a>].</div></li><li class="half_rhythm"><div>~50%-60% of individuals diagnosed with BOFS have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>TFAP2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#bofs.REF.milunsky.2011.22">Milunsky et al 2011</a>].</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, no instances of germline mosaicism have been reported.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with BOFS may appear to be negative because of failure to recognize the disorder in family members, milder phenotypic presentation, or early death of the parent before the onset of symptoms (e.g., premature graying). Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is 50%. BOFS is associated with almost complete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>; however, significant <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> has been observed [<a class="bk_pop" href="#bofs.REF.milunsky.2011.22">Milunsky et al 2011</a>].</div></li><li class="half_rhythm"><div>If the <i>TFAP2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#bofs.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk for BOFS because of the possibility of a milder phenotypic presentation in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with BOFS has a 50% chance of inheriting the <i>TFAP2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>TFAP2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="bofs.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#bofs.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="bofs.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>TFAP2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="bofs.Resources"><h2 id="_bofs_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>AmeriFace: The Cleft/Craniofacial Advocates</b></div><div>PO Box 751112</div><div>Las Vegas NV 89136</div><div><b>Phone:</b> 888-486-1209 (toll-free 24 hours); 702-769-9264</div><div><b>Fax:</b> 702-341-5351</div><div><b>Email:</b> info@ameriface.org</div><div><a href="http://www.ameriface.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ameriface.org</a></div></li><li class="half_rhythm"><div><b>Face Equality International</b></div><div>United Kingdom</div><div><b>Email:</b> info@faceequalityinternational.org</div><div><a href="https://faceequalityinternational.org/thealliance/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faceequalityinternational.org</a></div></li></ul></div><div id="bofs.Molecular_Genetics"><h2 id="_bofs_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="bofs.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Branchiooculofacial Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK55063/table/bofs.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bofs.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_bofs.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_bofs.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_bofs.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_bofs.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_bofs.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_bofs.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_bofs.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7020" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TFAP2A</i></a></td><td headers="hd_b_bofs.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7020" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6p24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_bofs.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P05549" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Transcription factor AP-2-alpha</a></td><td headers="hd_b_bofs.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/TFAP2A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TFAP2A database</a></td><td headers="hd_b_bofs.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TFAP2A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TFAP2A</a></td><td headers="hd_b_bofs.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TFAP2A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TFAP2A</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="bofs.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="bofs.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Branchiooculofacial Syndrome (<a href="/omim/107580,113620" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK55063/table/bofs.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bofs.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/107580" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">107580</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSCRIPTION FACTOR AP2-ALPHA; TFAP2A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/113620" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">113620</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BRANCHIOOCULOFACIAL SYNDROME; BOFS</td></tr></tbody></table></div></div><div id="bofs.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>TFAP2A is a retinoic acid-responsive member of the AP-2 family of transcription factors that regulate <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression during embryogenesis of the eye, ear, face, body wall, limbs, and neural tube [<a class="bk_pop" href="#bofs.REF.schorle.1996.235">Schorle et al 1996</a>, <a class="bk_pop" href="#bofs.REF.zhang.1996.238">Zhang et al 1996</a>, <a class="bk_pop" href="#bofs.REF.ahituv.2004.424">Ahituv et al 2004</a>, <a class="bk_pop" href="#bofs.REF.nelson.2004.72">Nelson &#x00026; Williams 2004</a>].</p><p><b>Gene structure.</b>
<i>TFAP2A</i> contains eight coding exons (reference sequence <a href="/nuccore/NM_003220.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003220.2</a>, <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001042425.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001042425.1</a>, <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001032280.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001032280.2</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK55063/#bofs.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Pathogenic variants within <i>TFAP2A</i> or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> result in the branchiooculofacial (BOF) syndrome. <a class="bk_pop" href="#bofs.REF.milunsky.2008.1171">Milunsky et al [2008]</a> described a <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> whole-gene deletion and four <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in the family) that resulted in BOFS. Additional pathogenic variants and familial deletions have now been described [<a class="bk_pop" href="#bofs.REF.gestri.2009.791">Gestri et al 2009</a>, <a class="bk_pop" href="#bofs.REF.stoetzel.2009.2141">Stoetzel et al 2009</a>, <a class="bk_pop" href="#bofs.REF.tekin.2009.427">Tekin et al 2009</a>, <a class="bk_pop" href="#bofs.REF.reiber.2010.994">Reiber et al 2010</a>, <a class="bk_pop" href="#bofs.REF.aliferis.2011.250">Aliferis et al 2011</a>, <a class="bk_pop" href="#bofs.REF.frascari.2012.550">Frascari et al 2012</a>, <a class="bk_pop" href="#bofs.REF.galliani.2012.357">Galliani et al 2012</a>, <a class="bk_pop" href="#bofs.REF.leblanc.2013.901">LeBlanc et al 2013</a>, <a class="bk_pop" href="#bofs.REF.murray.2013.371">Murray et al 2013</a>, <a class="bk_pop" href="#bofs.REF.g_nes.2014.41">G&#x000fc;nes et al 2014</a>, <a class="bk_pop" href="#bofs.REF.meshcheryakova.2015.148">Meshcheryakova et al 2015</a>, <a class="bk_pop" href="#bofs.REF.titheradge.2015.13">Titheradge et al 2015</a>, <a class="bk_pop" href="#bofs.REF.xiong.2015.1254806">Xiong et al 2015</a>, <a class="bk_pop" href="#bofs.REF.yi.2016.1412">Yi et al 2016</a>].</p><p>Although the pathogenic variants occur throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, a <a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a> region in exons 6 and 7 that harbors <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in about 90% of probands/families with BOFS has been identified [<a class="bk_pop" href="#bofs.REF.milunsky.2011.22">Milunsky et al 2011</a>].</p><p>Mosaicism has been detected in one family [<a class="bk_pop" href="#bofs.REF.milunsky.2011.22">Milunsky et al 2011</a>].</p><p>The molecular spectrum in 30 families with 41 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with BOFS included <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants (28/30; 93%), one <a class="def" href="/books/n/gene/glossary/def-item/frameshift-variant/">frameshift variant</a>, and one whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#bofs.REF.milunsky.2011.22">Milunsky et al 2011</a>]. <a class="bk_pop" href="#bofs.REF.tekin.2009.427">Tekin et al [2009]</a> reported a complex <i>TFAP2A</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> (deletion of 18 and <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> of 6 nucleotides) between amino acids 276 and 281 in an individual with BOFS. More than 30 missense/<a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> pathogenic variants have now been described along with several small deletions/insertions and fewer than five whole-gene deletions.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> TFAP2A protein comprises 437 amino acids. It has a central basic DNA binding region, a carboxy terminus helix-span-helix motif that mediates dimerization, and an amino terminus that contains a transactivation <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#bofs.REF.eckert.2005.246">Eckert et al 2005</a>]. The amino acids in the basic region of the DNA binding domain (exons 6 and 7) show high evolutionary conservation from <i>Homo sapiens</i> through <i>Ciona intestinalis</i> (transparent sea squirt) [<a class="bk_pop" href="#bofs.REF.milunsky.2008.1171">Milunsky et al 2008</a>].</p><p>In addition to its role in regulating <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression during embryogenesis, <i>TFAP2A</i> is also involved in tumorigenesis with protein expression levels affecting cell transformation, tumor growth, metastasis, and survival [<a class="bk_pop" href="#bofs.REF.jean.1998.16501">Jean et al 1998</a>, <a class="bk_pop" href="#bofs.REF.heimberger.2005.267">Heimberger et al 2005</a>, <a class="bk_pop" href="#bofs.REF.orso.2007.87">Orso et al 2007</a>]. Numerous gene interactions likely underlie the variability in <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> resulting from molecular defects involving TFAP2A. TFAP2A is known to be expressed in premigratory and migratory neural crest cells [<a class="bk_pop" href="#bofs.REF.hilgereversheim.2000.1">Hilger-Eversheim et al 2000</a>, <a class="bk_pop" href="#bofs.REF.li.2007.338">Li &#x00026; Cornell 2007</a>] and is required for early morphogenesis of the lens [<a class="bk_pop" href="#bofs.REF.gestri.2009.791">Gestri et al 2009</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> In humans, the described anomalies in BOFS appear to be related to pathogenic variants or deletions of <i>TFAP2A</i> leading to dysfunctional regulation especially during embryogenesis.</p><p>Loss or alteration of function of TFAP2A protein orthologs in zebrafish or mice result in facial clefting, limb anomalies, and defects of the eye, ear, body wall, neural tube, and heart outflow tract [<a class="bk_pop" href="#bofs.REF.schorle.1996.235">Schorle et al 1996</a>, <a class="bk_pop" href="#bofs.REF.zhang.1996.238">Zhang et al 1996</a>, <a class="bk_pop" href="#bofs.REF.nottoli.1998.13714">Nottoli et al 1998</a>, <a class="bk_pop" href="#bofs.REF.westmays.1999.46">West-Mays et al 1999</a>, <a class="bk_pop" href="#bofs.REF.brewer.2002.139">Brewer et al 2002</a>, <a class="bk_pop" href="#bofs.REF.holzschuh.2003.5741">Holzschuh et al 2003</a>, <a class="bk_pop" href="#bofs.REF.knight.2003.5755">Knight et al 2003</a>, <a class="bk_pop" href="#bofs.REF.ahituv.2004.424">Ahituv et al 2004</a>, <a class="bk_pop" href="#bofs.REF.brewer.2004.135">Brewer et al 2004</a>, <a class="bk_pop" href="#bofs.REF.nelson.2004.72">Nelson &#x00026; Williams 2004</a>, <a class="bk_pop" href="#bofs.REF.feng.2008.315">Feng et al 2008</a>].</p><p>A study by <a class="bk_pop" href="#bofs.REF.gestri.2009.791">Gestri et al [2009]</a> of the role of <i>TFAP2A</i> pathogenic variants in zebrafish eye morphogenesis revealed an association with a multitude of ocular pathologies. In addition, the pathogenic variants compromised the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> function, thereby sensitizing the developing eye to deleterious pathogenic variants of other genes including <i>bmp4</i> and <i>tcf711a</i> [<a class="bk_pop" href="#bofs.REF.gestri.2009.791">Gestri et al 2009</a>].</p><p><a class="bk_pop" href="#bofs.REF.damberg.2005.1281">Damberg [2005]</a> found that the AP-2 family may be involved in the regulation of the monoaminergic systems in the adult brain, resulting in neuropsychiatric disorders.</p><p><a class="bk_pop" href="#bofs.REF.brewer.2004.135">Brewer et al [2004]</a> noted that surviving mutated <i>Tcfap2a</i> mice have craniofacial anomalies, abnormal middle ear development, and defects in pigmentation.</p><p><a class="bk_pop" href="#bofs.REF.li.2013.3195">Li et al [2013]</a> demonstrated that several pathogenic variants in the DNA binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> can have <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> activity on wild type AP-2&#x003b1; protein. Hence, differences in activity due to <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a>, <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a>, or antimorphic alleles may lead to the phenotypic variability characteristic of BOFS</p></div></div><div id="bofs.References"><h2 id="_bofs_References_">References</h2><div id="bofs.Published_Guidelines__Consensus_Sta"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.milunsky.2011.22">Milunsky JM, Maher TM, Zhao G, Wang Z, Mulliken JB, Chitayat D, Clemens M, Stalker HJ, Bauer M, Burch M, Ch&#x000e9;nier S, Cunningham ML, Drack AV, Janssens S, Karlea A, Klatt R, Kini U, Klein O, Lachmeijer AM, Megarbane A, Mendelsohn NJ, Meschino WS, Mortier GR, Parkash S, Ray CR, Roberts A, Roberts A, Reardon W, Schnur RE, Smith R, Splitt M, Tezcan K, Whiteford ML, Wong DA, Zori R, Lin AE. Genotype-phenotype analysis of the branchio-oculo-facial syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:22–32.</span> [<a href="/pubmed/21204207" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21204207</span></a>]</div></li></ul></div><div id="bofs.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.ahituv.2004.424">Ahituv N, Erven A, Fuchs H, Guy K, Ashery-Padan R, Williams T, de Angelis MH, Avraham KB, Steel KP. An ENU-induced mutation in AP-2alpha leads to middle ear and ocular defects in Doarad mice. <span><span class="ref-journal">Mamm Genome. </span>2004;<span class="ref-vol">15</span>:424–32.</span> [<a href="/pubmed/15181535" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15181535</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.aliferis.2011.250">Aliferis K, Stoetzel C, Pelletier V, Hell&#x000e9; S, Angio&#x000ef;-Duprez K, Vigneron J, Leheup B, Marion V, Dollfus H. A novel TFAP2A mutation in familial branchio-oculo-facial syndrome with predominant ocular phenotype. <span><span class="ref-journal">Ophthalmic Genet. </span>2011;<span class="ref-vol">32</span>:250–5.</span> [<a href="/pubmed/21728810" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21728810</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.brewer.2004.135">Brewer S, Feng W, Huang J, Sullivan S, Williams T. Wnt1-Cre-mediated deletion of AP-2alpha causes multiple neural crest-related defects. <span><span class="ref-journal">Dev Biol. </span>2004;<span class="ref-vol">267</span>:135–52.</span> [<a href="/pubmed/14975722" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14975722</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.brewer.2002.139">Brewer S, Jiang X, Donaldson S, Williams T, Sucov HM. Requirement for AP-2alpha in cardiac outflow tract morphogenesis. <span><span class="ref-journal">Mech Dev. </span>2002;<span class="ref-vol">110</span>:139–49.</span> [<a href="/pubmed/11744375" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11744375</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.damberg.2005.1281">Damberg M. Transcription factor AP-2 and monoaminergic functions in the central nervous system. <span><span class="ref-journal">J Neural Transm. </span>2005;<span class="ref-vol">112</span>:1281–96.</span> [<a href="/pubmed/15959839" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15959839</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.eckert.2005.246">Eckert D, Buhl S, Weber S, J&#x000e4;ger R, Schorle H. The AP-2 family of transcription factors. <span><span class="ref-journal">Genome Biol. </span>2005;<span class="ref-vol">6</span>:246.</span> [<a href="/pmc/articles/PMC1414101/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1414101</span></a>] [<a href="/pubmed/16420676" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16420676</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.feng.2008.315">Feng W, Huang J, Zhang J, Williams T. Identification and analysis of a conserved Tcfap2a intronic enhancer element required for expression in facial and limb bud mesenchyme. <span><span class="ref-journal">Mol Cell Biol. </span>2008;<span class="ref-vol">28</span>:315–25.</span> [<a href="/pmc/articles/PMC2223317/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2223317</span></a>] [<a href="/pubmed/17984226" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17984226</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.frascari.2012.550">Frascari F, Bieth E, Galinier P, Just W, Mazereeuw-Hautier J. Branchio-oculo-facial syndrome. <span><span class="ref-journal">Ann Dermatol Venereol. </span>2012;<span class="ref-vol">139</span>:550–4.</span> [<a href="/pubmed/22963965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22963965</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.galliani.2012.357">Galliani E, Burglen L, Kadlub N, Just W, Sznajer Y, de Villemeur TB, Soupre V, Picard A, Vazquez MP. Craniofacial phenotype in the branchio-oculo-facial syndrome: four case reports. <span><span class="ref-journal">Cleft Palate Craniofac J. </span>2012;<span class="ref-vol">49</span>:357–64.</span> [<a href="/pubmed/21539471" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21539471</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.gestri.2009.791">Gestri G, Osborne RJ, Wyatt AW, Gerrelli D, Gribble S, Stewart H, Fryer A, Bunyan DJ, Prescott K, Collin JR, Fitzgerald T, Robinson D, Carter NP, Wilson SW, Ragge NK. Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators. <span><span class="ref-journal">Hum Genet. </span>2009;<span class="ref-vol">126</span>:791–803.</span> [<a href="/pmc/articles/PMC3083835/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3083835</span></a>] [<a href="/pubmed/19685247" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19685247</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.g_nes.2014.41">G&#x000fc;nes N, Cengiz FB, Duman D, Dervi&#x0015f;o&#x0011f;lu S, Tekin M, T&#x000fc;ys&#x000fc;z B. Branchio-oculo-facial syndrome in a newborn caused by a novel TFAP2A mutation. <span><span class="ref-journal">Genet Couns. </span>2014;<span class="ref-vol">25</span>:41–7.</span> [<a href="/pubmed/24783654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24783654</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.heimberger.2005.267">Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. <span><span class="ref-journal">Clin Cancer Res. </span>2005;<span class="ref-vol">11</span>:267–72.</span> [<a href="/pubmed/15671555" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15671555</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.hilgereversheim.2000.1">Hilger-Eversheim K, Moser M, Schorle H, Buettner R. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. <span><span class="ref-journal">Gene. </span>2000;2000;<span class="ref-vol">260</span>:1–12.</span> [<a href="/pubmed/11137286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11137286</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.holzschuh.2003.5741">Holzschuh J, Barrallo-Gimeno A, Ettl AK, Durr K, Knapik EW, Driever W. Noradrenergic neurons in the zebrafish hindbrain are induced by retinoic acid and require tfap2a for expression of the neurotransmitter phenotype. <span><span class="ref-journal">Development. </span>2003;<span class="ref-vol">130</span>:5741–54.</span> [<a href="/pubmed/14534139" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14534139</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.jean.1998.16501">Jean D, Gershenwald JE, Huang S, Luca M, Hudson MJ, Tainsky MA, Bar-Eli M. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. <span><span class="ref-journal">J Biol Chem. </span>1998;<span class="ref-vol">273</span>:16501–8.</span> [<a href="/pubmed/9632718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9632718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.knight.2003.5755">Knight RD, Nair S, Nelson SS, Afshar A, Javidan Y, Geisler R, Rauch GJ, Schilling TF. <em>lockjaw</em> encodes a zebrafish <em>tfap2a</em> required for early neural crest development. <span><span class="ref-journal">Development. </span>2003;<span class="ref-vol">130</span>:5755–68.</span> [<a href="/pubmed/14534133" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14534133</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.leblanc.2013.901">LeBlanc SK, Yu S, Barnett CP. 6p.24 microdeletion involving TFAP2A without classic features of branchio-oculo-facial syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2013;<span class="ref-vol">161A</span>:901–4.</span> [<a href="/pubmed/23495225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23495225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.li.2013.3195">Li H, Sheridan R, Williams T. Analysis of TFAP2A mutations in branchio-oculo-facial syndrome indicated functional complexity within the AP-2&#x003b1; DNA-binding domain. <span><span class="ref-journal">Hum Mol Genet. </span>2013;<span class="ref-vol">22</span>:3195–206.</span> [<a href="/pmc/articles/PMC3723307/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3723307</span></a>] [<a href="/pubmed/23578821" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23578821</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.li.2007.338">Li W, Cornell RA. Redundant activities of Tfap2a and Tfap2c are required for neural crest induction and development of other non-neural ectoderm derivatives in zebrafish embryos. <span><span class="ref-journal">Dev Biol. </span>2007;<span class="ref-vol">304</span>:338–54.</span> [<a href="/pmc/articles/PMC1904501/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1904501</span></a>] [<a href="/pubmed/17258188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17258188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.lin.2009.608">Lin AE, Yuzuriha S, McLean S, Mulliken JB. Lesser forms of cleft lip associated with the branchio-oculo-facial syndrome. <span><span class="ref-journal">J Craniofac Surg. </span>2009;<span class="ref-vol">20</span> Suppl 1:608–11.</span> [<a href="/pubmed/19795528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19795528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.meshcheryakova.2015.148">Meshcheryakova TI, Zinchenko RA, Vasilyeva TA, Marakhonov AV, Zhylina SS, Petrova NV, Kozhanova TV, Belenikin MS, Petrin AN, Mutovin GR. A clinical and molecular analysis of branchio-oculo-facial syndrome patients in Russia revealed new mutations in TFAP2A. <span><span class="ref-journal">Ann Hum Genet. </span>2015;<span class="ref-vol">79</span>:148–52.</span> [<a href="/pubmed/25590586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25590586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.milunsky.2008.1171">Milunsky JM, Maher TA, Zhao G, Roberts AE, Stalker HJ, Zori RT, Burch MN, Clemens M, Mulliken JB, Smith R, Lin AE. TFAP2A mutations result in branchio-oculo-facial syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">82</span>:1171–7.</span> [<a href="/pmc/articles/PMC2427243/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2427243</span></a>] [<a href="/pubmed/18423521" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18423521</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.milunsky.2011.22_1">Milunsky JM, Maher TM, Zhao G, Wang Z, Mulliken JB, Chitayat D, Clemens M, Stalker HJ, Bauer M, Burch M, Ch&#x000e9;nier S, Cunningham ML, Drack AV, Janssens S, Karlea A, Klatt R, Kini U, Klein O, Lachmeijer AM, Megarbane A, Mendelsohn NJ, Meschino WS, Mortier GR, Parkash S, Ray CR, Roberts A, Roberts A, Reardon W, Schnur RE, Smith R, Splitt M, Tezcan K, Whiteford ML, Wong DA, Zori R, Lin AE. Genotype-phenotype analysis of the branchio-oculo-facial syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:22–32.</span> [<a href="/pubmed/21204207" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21204207</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.murray.2013.371">Murray B, Wagle R, Amat-Alarcon N, Wilkens A, Stephens P, Zackai EH, Goldmuntz E, Calkins H, Deardorff MA, Judge DP. A family with a complex clinical presentation characterized by arrhythmogenic right ventricular dysplasia/cardiomyopathy and features of branchio-oculo-facial syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2013;<span class="ref-vol">161A</span>:371–6.</span> [<a href="/pubmed/23307527" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23307527</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.nelson.2004.72">Nelson DK, Williams T. Frontonasal process-specific disruption of AP-2alpha results in postnatal midfacial hypoplasia, vascular anomalies, and nasal cavity defects. <span><span class="ref-journal">Dev Biol. </span>2004;<span class="ref-vol">267</span>:72–92.</span> [<a href="/pubmed/14975718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14975718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.nottoli.1998.13714">Nottoli T, Hagopian-Donaldson S, Zhang J, Perkins A, Williams T. AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1998;<span class="ref-vol">95</span>:13714–9.</span> [<a href="/pmc/articles/PMC24885/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC24885</span></a>] [<a href="/pubmed/9811866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9811866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.orso.2007.87">Orso F, Fassetta M, Penna E, Solero A, De Filippo K, Sismondi P, De Bortoli M, Taverna D. The AP-2alpha transcription factor regulates tumor cell migration and apoptosis. <span><span class="ref-journal">Adv Exp Med Biol. </span>2007;<span class="ref-vol">604</span>:87–95.</span> [<a href="/pubmed/17695722" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17695722</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR. UK10K Consortium, Hurles ME. Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.raveh.2000.149">Raveh E, Papsin BC, Forte V. Branchio-oculo-facial syndrome. <span><span class="ref-journal">Int J Pediatr Otorhinolaryngol. </span>2000;<span class="ref-vol">53</span>:149–56.</span> [<a href="/pubmed/10906521" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10906521</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.reiber.2010.994">Reiber J, Sznajer Y, Posteguillo EG, M&#x000fc;ller D, Lyonnet S, Baumann C, Just W. Additional clinical and molecular analyses of TFAP2A in patients with the branchio-oculo-facial syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:994–9.</span> [<a href="/pubmed/20358615" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20358615</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.schorle.1996.235">Schorle H, Meier P, Buchert M, Jaenisch R, Mitchell PJ. Transcription factor AP-2 essential for cranial closure and craniofacial development. <span><span class="ref-journal">Nature. </span>1996;<span class="ref-vol">381</span>:235–8.</span> [<a href="/pubmed/8622765" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8622765</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.stoetzel.2009.2141">Stoetzel C, Riehm S, Bennouna Greene V, Pelletier V, Vigneron J, Leheup B, Marion V, Hell&#x000e9; S, Danse JM, Thibault C, Moulinier L, Veillon F, Dollfus H. Confirmation of TFAP2A gene involvement in branchio-oculo-facial syndrome (BOFS) and report of temporal bone anomalies. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:2141–6.</span> [<a href="/pubmed/19764023" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19764023</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.tekin.2009.427">Tekin M, Sirmaci A, Y&#x000fc;ksel-Konuk B, Fitoz S, Sennaro&#x0011f;lu L. A complex TFAP2A allele is associated with branchio-oculo-facial syndrome and inner ear malformation in a deaf child. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:427–30.</span> [<a href="/pubmed/19206157" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19206157</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.titheradge.2015.13">Titheradge HL, Patel C, Ragge NK. Branchio-oculo-facial syndrome: a three generational family with markedly variable phenotype including neonatal lethality. <span><span class="ref-journal">Clin Dysmorphol. </span>2015;<span class="ref-vol">24</span>:13–16.</span> [<a href="/pubmed/25325185" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25325185</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.westmays.1999.46">West-Mays JA, Zhang J, Nottoli T, Hagopian-Donaldson S, Libby D, Strissel KJ, Williams T. AP-2alpha transcription factor is required for early morphogenesis of the lens vesicle. <span><span class="ref-journal">Dev Biol. </span>1999;<span class="ref-vol">206</span>:46–62.</span> [<a href="/pubmed/9918694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9918694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.xiong.2015.1254806">Xiong HY, Alipanahi B, Lee LJ, Bretchneider H, Merico D, Yuen RK, Hua Y, Gueroussov S, Najafabadi HS, Hughes TR, Morris Q, Barash Y, Krainer AR, Jojic N, Scherer SW, Blencowe BJ, Frey BJ. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease. <span><span class="ref-journal">Science. </span>2015;<span class="ref-vol">347</span>:1254806.</span> [<a href="/pmc/articles/PMC4362528/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4362528</span></a>] [<a href="/pubmed/25525159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25525159</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.yi.2016.1412">Yi S, Albino FP, Wood BC, Sauerhammer TM, Rogers GF, Oh AK. An unconventional presentation of branchio-oculo-facial syndrome. <span><span class="ref-journal">J Craniofac Surg. </span>2016;<span class="ref-vol">27</span>:1412–14.</span> [<a href="/pubmed/27607113" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27607113</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bofs.REF.zhang.1996.238">Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, McMahon AP, Flavell RA, Williams T. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. <span><span class="ref-journal">Nature. </span>1996;<span class="ref-vol">381</span>:238–41.</span> [<a href="/pubmed/8622766" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8622766</span></a>]</div></li></ul></div></div><div id="bofs.Chapter_Notes"><h2 id="_bofs_Chapter_Notes_">Chapter Notes</h2><div id="bofs.Author_Notes"><h3>Author Notes</h3><p>As of January 2018, there is no disease advocacy organization ("support group") for BOFS. Through Dr Lin, several parents of children with BOFS have reached out to the families of newly diagnosed individuals.</p></div><div id="bofs.Acknowledgments"><h3>Acknowledgments</h3><p>We thank the many families and international colleagues who have supported our research.</p></div><div id="bofs.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>29 March 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>31 May 2011 (me) Review posted live</div></li><li class="half_rhythm"><div>11 January 2011 (al) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK55063</span><span class="label">PMID: <a href="/pubmed/21634087" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">21634087</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/bohring-opitz/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bor/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK55063&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK55063/?report=reader">PubReader</a></li><li><a href="/books/NBK55063/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK55063" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK55063" style="display:none" title="Cite this Page"><div class="bk_tt">Lin AE, Haldeman-Englert CR, Milunsky JM. Branchiooculofacial Syndrome. 2011 May 31 [Updated 2018 Mar 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK55063/pdf/Bookshelf_NBK55063.pdf">PDF version of this page</a> (952K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#bofs.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#bofs.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#bofs.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#bofs.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#bofs.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#bofs.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#bofs.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#bofs.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#bofs.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#bofs.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#bofs.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7020[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TFAP2A</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2476242" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2476242" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2476242" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2476242" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301581" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IRF6</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IRF6</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schutte BC, Saal HM, Goudy S, Leslie E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20556892" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TP63</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TP63</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sutton VR, van Bokhoven H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301712" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Focal Dermal Hypoplasia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Focal Dermal Hypoplasia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bostwick B, Van den Veyver IB, Sutton VR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21882399" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Kabuki Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Kabuki Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Adam MP, Hudgins L, Hannibal M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/19795528" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Lesser forms of cleft lip associated with the branchio-oculo-facial syndrome.</a><span class="source">[J Craniofac Surg. 2009]</span><div class="brieflinkpop offscreen_noflow">Lesser forms of cleft lip associated with the branchio-oculo-facial syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lin AE, Yuzuriha S, McLean S, Mulliken JB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Craniofac Surg. 2009 Mar; 20 Suppl 1:608-11. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=21634087" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=21634087" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0410d7dde089116991770f">Branchiooculofacial Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Branchiooculofacial Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:45:59-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A41A0E04093810000000003260135&amp;ncbi_session=CE8A41A0E0410D61_0806SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK55063%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK55063&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK55063/&amp;ncbi_pagename=Branchiooculofacial Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A41A0E0410D61_0806SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>